HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization.

AbstractOBJECTIVE:
To develop an effective HIV vaccine strategy that can induce cross-reactive neutralizing antibody.
METHODS:
Codon-optimized gp140 and gp145 env genes derived from HIV-1(cn54), a CRF07 B'/C recombinant strain, were constructed as DNA and recombinant Tiantan vaccinia (rTV) vaccines. The effect of heterologous immunization with gp140 and gp145 was tested in mice and guinea pigs. T cell responses were detected using the IFN-γ ELISPOT assay. A panel of primary isolates of clade B' and B'/C HIV-1 and TZM-bl cells was used to determine the neutralizing activity of immunized sera.
RESULTS:
The neutralizing antibodies (NAbs) induced by the heterologous immunogen immunization neutralized all HIV-1 B' and B'/C primary isolates in the guinea pig model. Gp145 and gp140 heterologous prime-boost induced the best neutralizing antibody response with a broad neutralizing spectrum and the highest titer of 1:270 at 6 weeks after the last inoculation. However, the T cell response to HIV-1 peptides was significantly weaker than the gp145+gp145 homologous prime-boost.
CONCLUSIONS:
This heterologous prime-boost immunization strategy could be used to design immunogen-generating broad neutralizing antibodies against genetic variance pathogens.
AuthorsLianxing Liu, Yanling Hao, Zhenwu Luo, Yang Huang, Xintao Hu, Ying Liu, Yiming Shao
JournalVaccine (Vaccine) Vol. 30 Issue 28 Pg. 4135-43 (Jun 13 2012) ISSN: 1873-2518 [Electronic] Netherlands
PMID22561314 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • AIDS Vaccines
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Vaccines, DNA
  • Vaccines, Subunit
  • env Gene Products, Human Immunodeficiency Virus
  • gp140 envelope protein, Human immunodeficiency virus 1
  • Interferon-gamma
Topics
  • AIDS Vaccines (administration & dosage, genetics, immunology)
  • Animals
  • Antibodies, Neutralizing (blood)
  • Antibodies, Viral (blood)
  • Enzyme-Linked Immunospot Assay
  • Female
  • Genetic Vectors
  • Guinea Pigs
  • HIV-1 (genetics, immunology)
  • Interferon-gamma (metabolism)
  • Mice
  • Mice, Inbred BALB C
  • Neutralization Tests
  • T-Lymphocytes (immunology)
  • Vaccination (methods)
  • Vaccines, DNA (administration & dosage, genetics, immunology)
  • Vaccines, Subunit (administration & dosage, genetics, immunology)
  • Vaccinia virus (genetics)
  • env Gene Products, Human Immunodeficiency Virus (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: